Gunilla Andersson - BioArctic Director HR

All Insiders . Sweden . 
Stock . BioArctic AB . Stakeholders . Insider . Gunilla Andersson
BIOA-B Stock  SEK 187.50  6.90  3.55%   

Insider

Gunilla Andersson is Director HR of BioArctic AB
Age 62
Phone46 86 95 69 30
Webhttps://www.bioarctic.se

BioArctic Management Efficiency

BioArctic's management efficiency ratios could be used to measure how well BioArctic manages its routine affairs as well as how well it operates its assets and liabilities.
BioArctic AB has accumulated 7.79 M in total debt with debt to equity ratio (D/E) of 3.0, implying the company greatly relies on financing operations through barrowing. BioArctic AB has a current ratio of 5.51, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist BioArctic until it has trouble settling it off, either with new capital or with free cash flow. So, BioArctic's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like BioArctic AB sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for BioArctic to invest in growth at high rates of return. When we think about BioArctic's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Linda HolmstromOncopeptides AB
N/A
Susanne LagerlundCantargia AB
N/A
Andrew McLeanCamurus AB
58
Johanna ChristensenCantargia AB
N/A
Sren MScHansa Biopharma AB
58
Ignacio GarciaRibasCantargia AB
N/A
Katja MargellHansa Biopharma AB
N/A
Pr MDOncopeptides AB
N/A
MSc MScOncopeptides AB
53
Jon AlonsoCamurus AB
50
Peter NygrenOncopeptides AB
64
Annette MattssonCamurus AB
57
Kristina LuthmanOncopeptides AB
N/A
Anne LannerHansa Biopharma AB
54
Nina ValkamaCantargia AB
N/A
Thoas MDCantargia AB
61
Jakob LicOncopeptides AB
51
Dominique TersagoCantargia AB
61
MSc MDOncopeptides AB
N/A
Emanuel BjrneHansa Biopharma AB
50
Rein BScCamurus AB
65
BioArctic AB , a research intensive biopharmaceutical company, develops disease modifying treatments and diagnostics for neurodegenerative diseases in Sweden. BioArctic AB was founded in 1992 and is headquartered in Stockholm, Sweden. BioArctic is traded on Stockholm Stock Exchange in Sweden. BioArctic AB (BIOA-B) is traded on Stockholm Exchange in Sweden and employs 61 people.

Management Performance

Return On Equity-0.0142
Return On Asset-0.0055

BioArctic AB Leadership Team

Elected by the shareholders, the BioArctic's board of directors comprises two types of representatives: BioArctic inside directors who are chosen from within the company, and outside directors, selected externally and held independent of BioArctic. The board's role is to monitor BioArctic's management team and ensure that shareholders' interests are well served. BioArctic's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, BioArctic's outside directors are responsible for providing unbiased perspectives on the board's policies.
Gunilla Andersson, Director HR
Pr Gellerfors, Sr CoFounder
Jan Mattsson, S Fin
Christer Mller, VP Officer
Gunilla Osswald, Chief Officer
Pr Lannfelt, VP CoFounder
Oskar Bosson, VP IR
Frida Lekander, Head Marketing
Johanna Flting, VP Research
Harald Borgeke, Head Affairs

BioArctic Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is BioArctic a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity-0.0142
Return On Asset-0.0055
Profit Margin(0.05) %
Operating Margin(0.03) %
Current Valuation26.19 B
Shares Outstanding73.73 M
Shares Owned By Insiders48.40 %
Shares Owned By Institutions30.39 %
Price To Earning12.95 X
Price To Book32.29 X

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Other Information on Investing in BioArctic Stock

BioArctic financial ratios help investors to determine whether BioArctic Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BioArctic with respect to the benefits of owning BioArctic security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY